GPT and Decreased liver function: In Toc-HDO-injected mice, we found a statistically significant decrease of liver dysfunction (ALT level) observed in the parent ASO-injected mice both at ED50 and ED95 levels, probably because of the reduction of the administered dose of the nucleotide.